Compound library / Fertility

Clomiphene Citrate (Clomid)

Oral SERM that blocks estrogen feedback at the pituitary, raising LH/FSH; first-line for inducing ovulation in women and commonly used off-label to raise testosterone/support fertility in men.

CategoryFertility
Regulatory standingApproved medicine
Typical routeOral
Half-life~5-7 days (with a much longer-acting metabolite)
Common dose rangeFemale: 50 mg/day for 5 days/cycle. Male: 12.5-50 mg every other day or daily.
Typical cycle lengthPer fertility specialist's cycle plan, or ongoing for male use

BioHack Track models Clomiphene Citrate (Clomid) at a half-life of 144 hours, so every dose you log is decayed against that curve and the app shows estimated active levels — not just what you typed.

Approved medicine

An FDA-approved product containing this compound exists, and its label is linked under Primary sources below. That label is the authority on dosing; the range on this page describes what people commonly track, including off-label use, and does not replace it.

Reconstitution

Oral tablet; no reconstitution needed.

Storage

Store at room temperature.

Cautions

Prescription medication. Can cause visual disturbances, mood changes, and ovarian hyperstimulation risk in women; requires monitoring.

Track Clomiphene Citrate (Clomid) in BioHack Track. Half-life, dose range and route come pre-filled from this library — log a dose and the app counts your vial down, models what is in your system, and puts it on the same chart as your labs and body composition.

Others in Fertility

Look up the research

These open a search of each database for Clomiphene Citrate (Clomid) — they are not citations, and nothing here is evidence for any particular dose. The same links are in the app.

Work it out

Where these figures come from

Primary sources for Clomiphene Citrate (Clomid)

The half-life, route and dose range on this page are compiled from published pharmacokinetic literature, manufacturer and product monographs where one exists, and the ranges commonly reported in clinical and research use. They are kept as a range rather than a single figure because that is what the sources actually support — a half-life varies with route, formulation and the person.

These are not citations, and this page is not a review of the evidence. Where a number matters to you, follow the database links above and read the source. We say so plainly rather than dressing a compiled reference up as one.

Nothing on this page has been reviewed by a named clinician. It is a reference for people already tracking a protocol, not a recommendation to start one.

Published by Creative Images LLC · Last updated · Corrections: support